DBVT Q3 2019 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$538M

Q3 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-7.7% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$31M-1127.4% margin

Net Income

-$31M-1124.5% margin

EPS (Diluted)

$-3.05

QoQ Revenue Growth

-18.8%

Cash Flow

Operating Cash Flow

-$34M

Free Cash Flow

-$35M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$185M

Total Liabilities

$82M

Stockholders' Equity

$103M

Cash & Equivalents

$88M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	-7.7%
Gross Profit	$3M	$3M	-7.7%
Operating Income	-$31M	-$51M	+39.1%
Net Income	-$31M	-$51M	+39.3%